FASLG and Osteopenia: Liu et al71 showed that systemic injection of SHEDs via the tail vein ameliorated OVX‐induced osteopenia by activating the Fas ligand (FasL)‐mediated Fas pathway, leading to up‐regulation of Tregs and down‐regulation of Th1 and Th17 cells.